Add Company
Join Now

BIOLYTEÂ Revenue and Competitors

License our Company Data API

Location

N/A

Total Funding

Hospital/Healthcare

Industry

Estimated Revenue & Valuation

  • BIOLYTEÂ's estimated annual revenue is currently $6.5M per year.(i)
  • BIOLYTEÂ's estimated revenue per employee is $294,545

Employee Data

  • BIOLYTEÂ has 22 Employees.(i)
  • BIOLYTEÂ grew their employee count by -4% last year.

BIOLYTEÂ's People

NameTitleEmail/Phone
1
CEOReveal Email/Phone
2
Chief Operating OfficerReveal Email/Phone
3
VP SalesReveal Email/Phone
4
Head Content Strategy & SocialReveal Email/Phone
5
Director ProcurementReveal Email/Phone
6
Director Business DevelopmentReveal Email/Phone
7
Director MarketingReveal Email/Phone
8
National Account ManagerReveal Email/Phone
9
Experiential Marketing ManagerReveal Email/Phone
10
Logistics ManagerReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$17M49-9%N/AN/A
#2
$36.5M14235%N/AN/A
#3
$0.1M6500%N/AN/A
#4
$17.3M6111%N/AN/A
#5
$25.7M9517%N/AN/A
#6
$13.4M442%N/AN/A
#7
$23M7717%N/AN/A
#8
$49.3M14210%N/AN/A
#9
$42.8M1447%N/AN/A
#10
$6.7M268%N/AN/A
Add Company

What Is BIOLYTEÂ?

BIOLYTE®, the IV in a bottle® is the first liquid supplement that offers the same benefits of IV rehydration therapy, but in a drinkable form. Our founder, Dr. Rollins, wanted to create a product that would bring the IV bag home to his wife when she was going through breast cancer. He used his experience in the hospital tailoring IV bags to his patients needs, to create BIOLYTE®, the IV in a bottle. Just one bottle of BIOLYTE® has the same amount of electrolytes as an IV bag plus natural ingredients that boost energy, ease stomach illness, and reduce muscle cramps. BIOLYTE® is family owned and on a mission to help people feel better.

keywords:N/A

N/A

Total Funding

22

Number of Employees

$6.5M

Revenue (est)

-4%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$2.2M22N/AN/A
#2
$3.2M22N/AN/A
#3
$2.2M22N/AN/A
#4
$2.2M22N/AN/A
#5
$2.5M22-29%N/A